December 2, 2013 · Comments Off on Fingerprint Cancer
Where a Cancer Lives May not be as Important as What it’s Made of Imagine...
May 31, 2013 · Comments Off on Stop Signals
Researchers at University of Colorado Cancer Center are discovering how androgens drive diseases such as breast and bladder cancers.
Tightening the body’s cancer-catching net
November 30, 2012 · Comments Off on Tightening the body’s cancer-catching net
At CU Cancer Center, researchers, discover how dinosaurs, diabetes, Star Trek extras and Keith Richards combine to keep the body cancer-free.
Splitting the Cancer Arrow
June 1, 2012 · Comments Off on Splitting the Cancer Arrow
Biomarkers and the precise therapies that target them will cure cancer by degrees—and change the way drugs do business.
Phase I Clinical Trials Put Cancer Patients on the Cutting Edge
December 7, 2011 · Comments Off on Phase I Clinical Trials Put Cancer Patients on the Cutting Edge
Patients like Joel Groebner and Ellen Smith are examples of people living at the cutting...
Serendipity by Design
December 5, 2011 · Comments Off on Serendipity by Design
By Garth Sundem In the University of Colorado Cancer Center’s fight against lung cancer, what...
May 26, 2011 · Comments Off on Motherhood Mystery
Cancer Center studies reveal link between pregnancy and breast cancer Story by Michele Conklin, Photos...
Exposing Cancer’s Roadmap
March 23, 2011 · Comments Off on Exposing Cancer’s Roadmap
Aik-Choon Tan stood outside a hospital room in Baltimore five years ago feeling helpless. The 28-year-old computer scientist was devoting his career to developing complex algorithms to help ferret out the workings of cancer genes. Yet, his work meant nothing to the four-year-old girl inside who was dying of cancer.
The Melanoma Puzzle
July 1, 2010 · Comments Off on The Melanoma Puzzle
Sitting around the dinner table each night, Shannon Clark and her three children play a game they call "High-Low" when each person shares the high point and the low point of their day.
June 1, 2015 · Comments Off on Promising trial results of brigatinib show that all next-gen ALK inhibitors may not be created equal
Phase I/II clinical trial results reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results for investigational drug brigatinib against ALK+ non-small cell lung cancer (NSCLC), with 58 of 78 ALK+ patients responding to treatment, including 50 of 70 patients who had progressed after previous treatment with crizotinib, the first licensed ALK inhibitor.
First-of-its-kind canine health study enrolls 3,000th golden retriever
April 14, 2015 · Comments Off on First-of-its-kind canine health study enrolls 3,000th golden retriever
In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy
February 24, 2015 · Comments Off on In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy
University of Colorado Cancer Center Joins world’s largest precision cancer research collaboration
February 23, 2015 · Comments Off on University of Colorado Cancer Center Joins world’s largest precision cancer research collaboration
Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
October 15, 2014 · Comments Off on Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
CU docs argue for updates to the existing model of oncogenesis, with profound implications for research and treatment ow.ly/RHLnX